Onconetix, Inc. Preferred Stock, Convertible, Conversion Price, Decrease
Onconetix, Inc. (ONCO) had Preferred Stock, Convertible, Conversion Price, Decrease of $175.00 per share as of 2025-07-16, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:PreferredStockConvertibleConversionPriceDecrease · last filed 2026-08-13
- 2025-07-16: Preferred Stock, Convertible, Conversion Price, Decrease $175.00; Preferred Stock, Convertible, Conversion Price, Decrease as first filed $3.50.
- 2025-06-30: Preferred Stock, Convertible, Conversion Price, Decrease 6 month $3.50.
| Period end | Preferred Stock, Convertible, Conversion Price, Decrease | Preferred Stock, Convertible, Conversion Price, Decrease as first filed | Preferred Stock, Convertible, Conversion Price, Decrease 6 month |
|---|---|---|---|
| 2025-07-16 | $175.00 10-Q · filed 2026-08-13 | $3.50 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.50 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |